Most importantly, we found that the percentage of CD4+CD28− and CD8+CD28− cells among tumor-infiltrated CD4 and CD8, respectively, were significantly lower in PEF-treated tumors in comparison with infiltrated CD4 and CD8 T cells in untreated tumors. Here, CD8A is linked to neoplasm.